IL99779A0 - 1-(3,4-dihydro-2-oxo-1h-quinolin-6-yl)-2-(4-(2-phenylethyl)piperidin-1-yl)ethanol and-ethanone,their preparation and their therapeutic application - Google Patents

1-(3,4-dihydro-2-oxo-1h-quinolin-6-yl)-2-(4-(2-phenylethyl)piperidin-1-yl)ethanol and-ethanone,their preparation and their therapeutic application

Info

Publication number
IL99779A0
IL99779A0 IL99779A IL9977991A IL99779A0 IL 99779 A0 IL99779 A0 IL 99779A0 IL 99779 A IL99779 A IL 99779A IL 9977991 A IL9977991 A IL 9977991A IL 99779 A0 IL99779 A0 IL 99779A0
Authority
IL
Israel
Prior art keywords
ethanone
quinolin
piperidin
phenylethyl
dihydro
Prior art date
Application number
IL99779A
Other languages
English (en)
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of IL99779A0 publication Critical patent/IL99779A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL99779A 1990-10-18 1991-10-17 1-(3,4-dihydro-2-oxo-1h-quinolin-6-yl)-2-(4-(2-phenylethyl)piperidin-1-yl)ethanol and-ethanone,their preparation and their therapeutic application IL99779A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9012872A FR2668149B1 (fr) 1990-10-18 1990-10-18 Le 1-(3,4-dihydro-2-oxo-1h-quinolein-6-yl)-2-[4-(2-phenyl-ethyl)piperidin-1-yl]ethanol, sa preparation et son application en therapeutique.

Publications (1)

Publication Number Publication Date
IL99779A0 true IL99779A0 (en) 1992-08-18

Family

ID=9401336

Family Applications (1)

Application Number Title Priority Date Filing Date
IL99779A IL99779A0 (en) 1990-10-18 1991-10-17 1-(3,4-dihydro-2-oxo-1h-quinolin-6-yl)-2-(4-(2-phenylethyl)piperidin-1-yl)ethanol and-ethanone,their preparation and their therapeutic application

Country Status (18)

Country Link
US (1) US5212181A (cs)
EP (1) EP0481853A1 (cs)
JP (1) JPH04257579A (cs)
KR (1) KR920008029A (cs)
AU (1) AU638173B2 (cs)
CA (1) CA2052760A1 (cs)
CS (1) CS315291A3 (cs)
FI (1) FI914906L (cs)
FR (1) FR2668149B1 (cs)
HU (1) HUT59391A (cs)
IE (1) IE913653A1 (cs)
IL (1) IL99779A0 (cs)
MX (1) MX9101604A (cs)
NO (1) NO914071L (cs)
NZ (1) NZ240261A (cs)
PL (1) PL292089A1 (cs)
PT (1) PT99247A (cs)
ZA (1) ZA918293B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0524846A1 (fr) * 1991-06-27 1993-01-27 Synthelabo Dérivés de 2-(pipéridin-1-y1) éthanol, leur préparation et leur application en thérapeutique
US6255322B1 (en) * 1992-06-19 2001-07-03 Pfizer Inc. 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
JP2686887B2 (ja) * 1992-08-11 1997-12-08 キッセイ薬品工業株式会社 ピペリジノ−３，４−ジヒドロカルボスチリル誘導体
FR2699534B1 (fr) * 1992-12-21 1995-02-03 Synthelabo Dérivés de alpha-thiényl-pipéridine-1-éthanol, leur préparation et leur application en thérapeutique.
ZA9610736B (en) 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
AU7474998A (en) * 1997-05-07 1998-11-27 Emory University Haloisoquinoline carboxamide
WO2004011430A1 (ja) * 2002-07-25 2004-02-05 Yamanouchi Pharmaceutical Co., Ltd. ナトリウムチャネル阻害剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
US5212181A (en) 1993-05-18
FI914906A7 (fi) 1992-04-19
EP0481853A1 (fr) 1992-04-22
HUT59391A (en) 1992-05-28
IE913653A1 (en) 1992-04-22
NZ240261A (en) 1993-01-27
FI914906A0 (fi) 1991-10-17
PL292089A1 (en) 1992-06-26
CS315291A3 (en) 1992-05-13
AU8589291A (en) 1992-04-30
HU913267D0 (en) 1992-01-28
NO914071L (no) 1992-04-21
FI914906L (fi) 1992-04-19
FR2668149B1 (fr) 1994-09-23
MX9101604A (es) 1992-06-05
JPH04257579A (ja) 1992-09-11
PT99247A (pt) 1992-08-31
FR2668149A1 (fr) 1992-04-24
NO914071D0 (no) 1991-10-17
AU638173B2 (en) 1993-06-17
KR920008029A (ko) 1992-05-27
CA2052760A1 (en) 1992-04-19
ZA918293B (en) 1992-07-29

Similar Documents

Publication Publication Date Title
GB9515775D0 (en) Piperidine derivatives and their use as therapeutic agents
HU9402827D0 (en) 4-[4'-piperidinyl or 3'pirrolidinyl] substituted imidazoles as h3-receptor antagonists and therapeutic uses thereof
NZ325845A (en) 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives, preparation and pharmaceutical use thereof
ZA911650B (en) Derivatives of 4-(aminomethyl)piperidine,their preparation and their therapeutic application
ZA892259B (en) New 2,3,4-substituted imidazoles and 3,4,5-substituted 1,2,4-triazoles,the preparation and use thereof
IL99779A0 (en) 1-(3,4-dihydro-2-oxo-1h-quinolin-6-yl)-2-(4-(2-phenylethyl)piperidin-1-yl)ethanol and-ethanone,their preparation and their therapeutic application
AU2047588A (en) 2-((4-piperidyl)methyl)-1,2,3,4-tetrahydroisoquinoline derivatives, their preparation and their application in therapy
IL102334A0 (en) 2-(1-piperidyl)ethanol derivatives,their preparation and their therapeutic application
EP0714890A3 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
IL107133A0 (en) Piperidine derivatives,their preparation and their application in therapy
AU631334B2 (en) 2-substituted n,n'-ditrimethoxybenzoyl piperazines, and therapeutic compositions containing them
NZ239186A (en) Substituted 2-(9-fluorenonyl)-carbapenem derivatives and pharmaceutical
IL90909A0 (en) ((4-piperidyl)methyl)-2.3-dihydro-1h-isoindole and-2.3.4.5.-tetrahydro-1h-benzazepine derivatives their preparation and their application in therapy
IL97859A0 (en) 1,5-benzothiazepinone derivatives,their preparation and pharmaceutical use
GB9621419D0 (en) 3-3-disubstituted piperidine derivatives and their use as therapeutic agents
ITMI912520A0 (it) Procedimento per la preparazione di 1-(25)-3-merca-prometil-1-ossoprofil-l-prolina
AU653800B2 (en) 5,7-dihydroxy-2-methyl-8-{4-(3-hydroxy-1-(1-propyl) piperidinyl}-4H-1-benzophyran-4-one, its preparation and its use
IL74532A0 (en) 1-(4-quinolyl)-2-(4-piperidyl)-ethanamine and-propanamine derivatives,their preparation and pharmaceutical compositions comprising the same
GB2246513B (en) Therapeutic use of piperidine-2,6-diones
ZA924789B (en) 2-(1-piperidyl)ethanol derivatives,their preparation and their therapeutic application
PH24948A (en) 2-(2,2-difluorocyclopropyl)-alkylester and use as insecticide and acaricide
GB8915315D0 (en) Pharmaceutical compositions for use against hypertension and congestive heart failure
IL103488A0 (en) Polychlorodipyrido-imidazolium compounds and their use in the preparation of pentachloropyridine
BR9506859A (pt) "2-(4-metaxifenóxi)-3-piridinamina suas composições farmacêuticas e uso terapêutico
IL114619A0 (en) 7-Substituted 1-(4-(1H-1,2,4-triazol-1-yl-methyl)phenyl) substituted quinolonecarboxylic acids their preparation and pharmaceutical compositions containing them